Compare MDIA & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDIA | ZTEK |
|---|---|---|
| Founded | 2019 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Broadcasting | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.3M | 89.3M |
| IPO Year | N/A | N/A |
| Metric | MDIA | ZTEK |
|---|---|---|
| Price | $0.61 | $0.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.4K | ★ 47.3K |
| Earning Date | 11-19-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $127,477,000.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 83.96 | ★ 2225.73 |
| 52 Week Low | $0.62 | $0.62 |
| 52 Week High | $1.60 | $1.84 |
| Indicator | MDIA | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 21.90 | 48.24 |
| Support Level | $0.66 | $0.64 |
| Resistance Level | $0.71 | $0.76 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 0.03 | 64.78 |
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.